Mallmin H

Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty-results from a randomized placebo-controlled clinical trial.

Sköld C, Kultima K, Freyhult E, ..., Hailer NP, Mallmin H

Osteoporos Int 33 (9) 1-8 [2022-09-00; online 2022-05-24]

Affinity Proteomics Uppsala [Service]